Correction: Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management.
Saved in:
| Title: | Correction: Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management. |
|---|---|
| Authors: | Park YH; Division of Haematology-Oncology, Department of Medicine, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Lee SC; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore., Singer CF; Department of Obstetrics and Gynaecology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria., Balmaña J; Department of Medical Oncology, University Hospital Campus Vall Hebron, Barcelona, Spain., Dent RA; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Tan VK; Department of Breast Surgery, Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Mulansari NA; Haematology-Medical Oncology Division, Internal Medicine Department, Cipto Mangunkusumo National General Hospital/Universitas Indonesia, Jakarta, Indonesia., Yusof MM; Picaso Cancer Centre, Hospital Picaso, Petaling Jaya, Selangor, Malaysia., Que FVF; Department of Internal Medicine and Oncology, St Luke's Medical Center, Quezon City and Global City, Metro Manila, Philippines., Lu YS; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Parinyanitikul N; Medical Oncology Unit, King Chulalongkorn Memorial Hospital, Bangkok, Thailand., Pham CP; The Nuclear Medicine and Oncology Center, Bachmai Hospital, Hanoi, Vietnam.; Nuclear Medicine Department, Hanoi Medical University, Hanoi, Vietnam.; Oncology and Nuclear Medicine Department, University of Medicine and Pharmacy, Vietnam National University, Hanoi, Vietnam., Taib NA; Department of Surgery, Faculty of Medicine, University Malaya, UM Cancer Research Institute, Kuala Lumpur, Malaysia., Kong SY; Department of Laboratory Medicine and Genetic Counselling Clinic, National Cancer Center, Goyang, Gyeonggi-do, Republic of Korea., Antill Y; Familial Cancer Centre, Royal Melbourne Hospital, Melbourne, VIC, Australia.; Faculty of Medicine and Health Sciences, Monash University, Melbourne, VIC, Australia., Kim HJ; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. |
| Source: | Frontiers in oncology [Front Oncol] 2026 Mar 09; Vol. 16, pp. 1807980. Date of Electronic Publication: 2026 Mar 09 (Print Publication: 2026). |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41878532 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Correction: Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Park+YH%22">Park YH</searchLink>; Division of Haematology-Oncology, Department of Medicine, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+SC%22">Lee SC</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Singer+CF%22">Singer CF</searchLink>; Department of Obstetrics and Gynaecology, Comprehensive Cancer Centre, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Balmaña+J%22">Balmaña J</searchLink>; Department of Medical Oncology, University Hospital Campus Vall Hebron, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Dent+RA%22">Dent RA</searchLink>; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Tan+VK%22">Tan VK</searchLink>; Department of Breast Surgery, Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Mulansari+NA%22">Mulansari NA</searchLink>; Haematology-Medical Oncology Division, Internal Medicine Department, Cipto Mangunkusumo National General Hospital/Universitas Indonesia, Jakarta, Indonesia.<br /><searchLink fieldCode="AU" term="%22Yusof+MM%22">Yusof MM</searchLink>; Picaso Cancer Centre, Hospital Picaso, Petaling Jaya, Selangor, Malaysia.<br /><searchLink fieldCode="AU" term="%22Que+FVF%22">Que FVF</searchLink>; Department of Internal Medicine and Oncology, St Luke's Medical Center, Quezon City and Global City, Metro Manila, Philippines.<br /><searchLink fieldCode="AU" term="%22Lu+YS%22">Lu YS</searchLink>; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Parinyanitikul+N%22">Parinyanitikul N</searchLink>; Medical Oncology Unit, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.<br /><searchLink fieldCode="AU" term="%22Pham+CP%22">Pham CP</searchLink>; The Nuclear Medicine and Oncology Center, Bachmai Hospital, Hanoi, Vietnam.; Nuclear Medicine Department, Hanoi Medical University, Hanoi, Vietnam.; Oncology and Nuclear Medicine Department, University of Medicine and Pharmacy, Vietnam National University, Hanoi, Vietnam.<br /><searchLink fieldCode="AU" term="%22Taib+NA%22">Taib NA</searchLink>; Department of Surgery, Faculty of Medicine, University Malaya, UM Cancer Research Institute, Kuala Lumpur, Malaysia.<br /><searchLink fieldCode="AU" term="%22Kong+SY%22">Kong SY</searchLink>; Department of Laboratory Medicine and Genetic Counselling Clinic, National Cancer Center, Goyang, Gyeonggi-do, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Antill+Y%22">Antill Y</searchLink>; Familial Cancer Centre, Royal Melbourne Hospital, Melbourne, VIC, Australia.; Faculty of Medicine and Health Sciences, Monash University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Kim+HJ%22">Kim HJ</searchLink>; Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2026 Mar 09; Vol. 16, pp. 1807980. <i>Date of Electronic Publication: </i>2026 Mar 09 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41878532 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2026.1807980 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1807980 Titles: – TitleFull: Correction: Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Park YH – PersonEntity: Name: NameFull: Lee SC – PersonEntity: Name: NameFull: Singer CF – PersonEntity: Name: NameFull: Balmaña J – PersonEntity: Name: NameFull: Dent RA – PersonEntity: Name: NameFull: Tan VK – PersonEntity: Name: NameFull: Mulansari NA – PersonEntity: Name: NameFull: Yusof MM – PersonEntity: Name: NameFull: Que FVF – PersonEntity: Name: NameFull: Lu YS – PersonEntity: Name: NameFull: Parinyanitikul N – PersonEntity: Name: NameFull: Pham CP – PersonEntity: Name: NameFull: Taib NA – PersonEntity: Name: NameFull: Kong SY – PersonEntity: Name: NameFull: Antill Y – PersonEntity: Name: NameFull: Kim HJ IsPartOfRelationships: – BibEntity: Dates: – D: 09 M: 03 Text: 2026 Mar 09 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 16 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |